Contract research organisations (CROs) that conduct biopharmaceutical research in vivo are known as in-vivo contract research organisations (IVCROs). With the increasing popularity of biologics over small molecule medications, in-vivo CROs are becoming more common. Due to the high level of competition in the development of mABs, CROs are focusing more on biosimilar development.
Recent Comments